Questions/Business/ManagementMicroeconomics this is for Nitkkr
There have been several mergers of large firms within oligopolies. In this assignment, you are to select one merger that has been approved by the Federal Trade Commission (FTC) in the last five years; describe and analyze the impact of those mergers, on industry, on consumers, and on society as a whole. Complete the following:
Go to the Federal Trade Commission’s Web site and select 1 merger that the FTC has approved in the last five years. Write a paper that describes the principle firms, their industry, and that summarizes arguments in support of the merger and arguments opposing the merger. The paper should be approximately 2 pages in length, excluding the title page and bibliography. In addition to the 2 pages of content, include a title page, abstract, and bibliography. Some Things to Consider: Industry Description
Consider the following:
Describe the firms in the proposed merger. List their annual sales, and extent of their operations. From the firms’ point of view, what are some of the incentives to consolidate? Describe the competitive environment within the industry. Some Things to Consider: Summaries
Consider the following:
Explain whether the competitive environment in this industry benefits society or not. Is a high degree of market concentration a boon or threat to consumers? Explain. How would the merger benefit the firms? Would it benefit society or not? Explain. You might use one or more of the following concepts: productive efficiency or administrative efficiency.
Join now or log in to start viewing answers.
Report DMCA
NITKKRA+ 1396 TUTOR Posted 3102. Sold 3556. Bought 3. Asked 5. Solution preview:
There have been several mergers of large firms within oligopolies In this assign***** *** *** ** ****** *** ****** **** *** **** ******** ** *** ******* ***** Commission ***** ** *** **** **** ****** ******** *** ******* *** ****** ** ***** ******** ** industry, ** consumers, *** ** ******* ** * ***** ******** *** following
Attachments
FTC MERGER.docx
INTRODUCTION
FTC as Federal Trade Commission takes preventive steps that cannot **** *** consumers ** *** accepting *** **** ** ******* ***** ** ****** ** *** ******* *** *** *** ****** ** ******* *** ******** **** ** ** efficient ****** ******** *** consumers **** ****** ** benefited **** *** ****** **** transforms *** ****** ** **** ******* ******** *** ******** ******** technology *** ****** ***** **** **** opportunity *** **** ****** ** ******* *** ****** **** *** **** ********
*** ******** ******
*** *** *** ******** ****** ** **** International *** *** Pharmaceuticals **** **** ** *** ***** ***** *** approving *** ******* ****** ****** ** ******* *** ****** advantage *** **** according ** *** **** ** ******* *** ******** advantage *** ****** ******** **** ** ** *** ****** **** ******** *** ******* ** *** ******* ** assisting *** **** ** *** ****** **** ****** ** ***** ** ** ****** ** ** antipetitive ****** *** **** *** ** ** ***** ** ****** *** ******* *** ****** ** ****** *** ******* ***** **** **** **** ** ***** ******* ***** ** ******* conditions *** ****** ***** *** ** consumers ******** *** ****** *** ******** *** ******** ** *** ***
****** ** ******* ** INDUSTRY, CONSUMERS *** *******
*** ****** ** ***** ******* *** considered societys ******* ******** ** providing *** ******* ***** **** **** ***** ******** *** *** suffering **** ****** *** ****** ******* condition ******* conditions **** ******* treatments *** ***** ***** ***** ******* ******* ***** ******* ******** ** *** ****** industry, *** ****** *** * ****** ****** ** ** considers *** ***** **** ***** **** emphasize *** ******** technology **** ** ******** ** *** ********
Consumers *** benefited **** **** ****** ** ** ** ** ******** **** ******** *** ******** ***** *** ***** efficiently **** ***** considering *** ******** ****** ** ** ******* ** extensive ******* **** ***** *** **** ****** *** ******** *** *** ** ****** ******* ***** *** ****** *** *******
*** ** ******** ******** ***** ** **** ******* ******** *** international ****** ** benefiting ******* *** understanding ** **** ******** ** ** ** ******* ******* deceptive ***** **** *** **** ******* *** ****** practices ***** ******** ** *** ****** ******** *** developmental ******* ******* ******* * ******** *****
******** DESCRIPTION
*** principle ***** ** *** ****** *** **** International *** *** Pharmaceuticals *** ****** ****** ** ** * **** *** *** ****** ******** *** *** ******** ** *** ** ** ***** ** **** practices **** ***** ** efficient *** effective ** * ******* ** ***** ** ** * ******* ****** ****** *** **** *** ****** **** **** ******* ** ******** *** ******* ******* *** ******* *** ******
** ** researched **** **** International *** ** **** *** ** ****** *** **** *** *** ***** ** **** *** ******* ******* ***** ******* *** **** **** ***** **** *** ********
*** different ***** ** ****** *** methimazole ******* **** *** ******* **** *** excessive ******* production ** *** ******* ***** ** ** * horizontal agreement ** ** describes *** ****** **** *** *** deployment ** ******
COMPETITVE ENVIRONMENT
*** ******** environment ** **** ******** *** benefited *** ******* ** *** ******* ******** **** **** ******* ** ***** *** *** effective ***** ** definitely ******** *** ******* ** mentioned **** *** ****** **** ******** ** providing **** ****** ******** ***** ******* * ******** ******
*** ******* ****** ** ****** concentration ** * **** ** consumers ** consumers *** ****** discounted **** *** ***** **** *** **** oligopolistic ****** **** ****** ** * ******* **** *** ***** ** ** ******** *** ******** advantage Productive efficiency *** ******** *** importance *** acceptance ***** **** ****** *** ****** ******** ** *** ***
CONCLUSION
* coordinated ***** *** ***** *** importance ** ****** **** ******* ******** *** ****** *** ******* ***** ******** positively **** efficient productivity ********
REFERENCES
* ****** ******* * * ******* * ****** Cunningham, Effective ******** ** ******** ******* ** Concentrated Markets, ** ANTITRUST ******** *****Price: $15.00